BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2427 related articles for article (PubMed ID: 23328709)

  • 1. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients.
    Lin HY; Hwang DY; Lee SC; Kuo HT; Kuo MC; Chang JM; Tsai JC; Hung CC; Hwang SJ; Chen HC
    Clin Chem Lab Med; 2015 Jan; 53(1):73-83. PubMed ID: 25153411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
    Liu KD; Yang W; Anderson AH; Feldman HI; Demirjian S; Hamano T; He J; Lash J; Lustigova E; Rosas SE; Simonson MS; Tao K; Hsu CY;
    Kidney Int; 2013 May; 83(5):909-14. PubMed ID: 23344473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D; Lacquaniti A; Coppolino G; Donato V; Campo S; Fazio MR; Nicocia G; Buemi M
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):337-44. PubMed ID: 19176795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine neutrophil gelatinase-associated lipocalin and kidney injury in children with focal segmental glomerulosclerosis.
    Youssef DM; El-Shal AA
    Iran J Kidney Dis; 2012 Sep; 6(5):355-60. PubMed ID: 22976261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study.
    Nielsen SE; Hansen HP; Jensen BR; Parving HH; Rossing P
    Nephron Clin Pract; 2011; 118(2):c130-5. PubMed ID: 21160226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Liu KD; Yang W; Go AS; Anderson AH; Feldman HI; Fischer MJ; He J; Kallem RR; Kusek JW; Master SR; Miller ER; Rosas SE; Steigerwalt S; Tao K; Weir MR; Hsu CY;
    Am J Kidney Dis; 2015 Feb; 65(2):267-74. PubMed ID: 25311702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
    Bolignano D; Lacquaniti A; Coppolino G; Campo S; Arena A; Buemi M
    Kidney Blood Press Res; 2008; 31(4):255-8. PubMed ID: 18600028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
    Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease.
    Hasegawa M; Ishii J; Kitagawa F; Takahashi K; Hayashi H; Koide S; Tomita M; Takahashi H; Ozaki Y; Yuzawa Y
    Heart Vessels; 2015 Jan; 30(1):81-8. PubMed ID: 24378882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine.
    Buelow MW; Dall A; Regner K; Weinberg C; Bartz PJ; Sowinski J; Rudd N; Katzmark L; Tweddell JS; Earing MG
    Congenit Heart Dis; 2012; 7(5):441-7. PubMed ID: 22537138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
    Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
    Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy.
    Sola-Del Valle DA; Mohan S; Cheng JT; Paragas NA; Sise ME; D'Agati VD; Barasch J
    Nephrol Dial Transplant; 2011 Jul; 26(7):2387-90. PubMed ID: 21555394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of urinary NGAL, serum creatinine standardization and estimated glomerular filtration rate in resistant hypertension.
    Prkacin I; Ozvald I; Cavrić G; Balenović D; Bulum T; Flegar-Mestrić Z
    Coll Antropol; 2013 Sep; 37(3):821-5. PubMed ID: 24308223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA; Köttgen A; Coresh J; Astor BC
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 122.